Oxidative stress during myocardial ischaemia and heart failure
- PMID: 9519346
Oxidative stress during myocardial ischaemia and heart failure
Abstract
Oxidative stress is a condition in which oxidant metabolites exert toxic effects because of their increased production or an altered cellular mechanism of protection. The heart needs oxygen but it is also susceptible to oxidative stress, which occurs during post-ischaemic reperfusion, for example. Ischaemia causes alterations in the defence mechanisms against oxygen free radicals. At the same time, production of oxygen free radicals increases. In man, there is evidence of oxidative stress during surgical reperfusion of the whole heart, or after thrombolysis, and it is related to transient left ventricular dysfunction or stunning. At present, there are few data on oxidative stress in the failing heart. It is not clear whether the defence mechanisms of the myocyte are altered or whether the production of oxygen free radicals is increased, or both. Recent data have shown a close link between oxidative stress and apoptosis. Importantly, tumour necrosis factor causes a rapid rise in intracellular reactive oxygen intermediates and apoptosis. This series of events is not confined to the myocytes, but also occurs at the level of endothelium, where tumour necrosis factor causes expression of inducible nitric oxide synthase, production of the reactive radical nitric oxide, oxidative stress and apoptosis. The immunological response to heart failure may result in endothelial and myocyte dysfunction through oxidative stress-mediated apoptosis. A better understanding of these mechanisms may lead to novel therapeutic strategies.
Similar articles
-
Oxidative stress and ischemic myocardial syndromes.Med Sci Monit. 2009 Oct;15(10):RA209-219. Med Sci Monit. 2009. PMID: 19789524 Review.
-
Mitochondrial oxidative stress and dysfunction in myocardial remodelling.Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review.
-
Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.Free Radic Biol Med. 2007 Jul 15;43(2):271-81. doi: 10.1016/j.freeradbiomed.2007.04.021. Epub 2007 Apr 29. Free Radic Biol Med. 2007. PMID: 17603936
-
Oxidative stress during myocardial ischaemia and heart failure.Curr Pharm Des. 2004;10(14):1699-711. doi: 10.2174/1381612043384718. Curr Pharm Des. 2004. PMID: 15134567 Review.
-
Metabolic disarrangement in ischemic heart disease and its therapeutic control.Rev Port Cardiol. 1998 Sep;17(9):667-84. Rev Port Cardiol. 1998. PMID: 9834638 Review.
Cited by
-
Effects of Panax ginseng and ginsenosides on oxidative stress and cardiovascular diseases: pharmacological and therapeutic roles.J Ginseng Res. 2022 Jan;46(1):33-38. doi: 10.1016/j.jgr.2021.07.007. Epub 2021 Jul 26. J Ginseng Res. 2022. PMID: 35058725 Free PMC article. Review.
-
Vitamin C: historical perspectives and heart failure.Heart Fail Rev. 2021 May;26(3):699-709. doi: 10.1007/s10741-020-10036-y. Epub 2020 Oct 8. Heart Fail Rev. 2021. PMID: 33033908 Review.
-
The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury.Exp Ther Med. 2018 Jun;15(6):5231-5242. doi: 10.3892/etm.2018.6097. Epub 2018 Apr 25. Exp Ther Med. 2018. PMID: 29904407 Free PMC article.
-
Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects.Naunyn Schmiedebergs Arch Pharmacol. 2017 Mar;390(3):245-252. doi: 10.1007/s00210-016-1323-6. Epub 2016 Dec 8. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 27928616
-
Molecular Evolution of the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene Nrf2 in Old World Fruit Bats (Chiroptera: Pteropodidae).PLoS One. 2016 Jan 6;11(1):e0146274. doi: 10.1371/journal.pone.0146274. eCollection 2016. PLoS One. 2016. PMID: 26735303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical